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Abstract
Within  a  decade  the  family  of  AlkB  dioxygenases  have  been  extensively
studied as a one-protein DNA/RNA repair system in E. coli but also as a group
of much wider function proteins in eukaryotes. Two strains, HK82 and BS87,
are the most commonly used E. coli  strains for alkB gene mutations. The aim
of this study was to assess the usefulness of these alkB mutants in different
aspects of research on AlkB dioxygenases functions not only in alkylated DNA
repair but also in other metabolic processess in cells. Using of HK82 and BS87
strains we found the following differences among these alkB‾ strains: (i) HK82
has  shown  more  than  10-fold  higher  MMS-induced  mutagenesis  in
comparison to BS87; (ii) different specificity of Arg+ revertants; (iii) increased
induction of SOS and Ada responses in HK82; (iv) HK82 DNA, in comparison to
AB1157 and BS87, contains additional mutations: nalA,  sbcC, and nuoC.  We
hypothesize that in HK82 these mutations together with the non-functional
AlkB protein may result in much higher contents of ssDNA, thus higher in
comparison to BS87, MMS-induced mutagenesis.
In the light of our findings, we strongly recommend using BS87 strain in AlkB
research as HK82, bearing several additional mutations in its genome, is not
an exact derivative of the AB1157 strain, and shows additional features that
may disturb proper interpretation of obtained results.
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1. Introduction
The alkB locus was reported 30 years ago in Mutsuo Sekiguchi’s laboratory,
nonetheless, the biological function of AlkB protein has been discovered only
20 years later [1-3]. This enzyme has appeared to function as a one-protein
DNA  repair  system  whose  action  depends  on  one  co-substrate,  2-
oxoglutarate (2OG), and two cofactors, Fe(II) and O2. It acts both, on DNA and
RNA and reverts N1-methyladenine (1meA) and N3-methylcytosine (3meC)
residues  back  to  natural  bases.  Bioinformatic  analysis  placed  AlkB  in  the
superfamily of  2OG and Fe(II)-dependent dioxygenases found in almost all
organisms [4].  Multiplicity of AlkB homologs, especially in eukaryotes, e.g.
nine in humans (ALKBH1-8 and FTO), 13 in Arabidopsis thaliana, suggests a
variety of functions exerted by these proteins. 
In 1983 Kataoka and coworkers [5] isolated as E. coli alkB –  mutant specified
as HK82 that to this day serves as the most frequently used tool to determine
a variety of  AlkB features. The HK82 comes from the  E. coli K12 AB1157
strain  mutagenized with MNNG/EMS and the subsequent  isolation of  MMS
sensitive and UV-light resistant colonies. Mutation localization was done by
replica  plating  method,  P1  transduction,  and  more  precise  mapping  by
crossing  each  mutant  with  Hfr  strains.  The mutation  of  one of  the  MMS-
sensitive  isolates,  HK22  (alkB22),  was  mapped  between  nalA and  nrdB
markers.  In  the  next  step,  a  spontaneous  nalidixic  acid  resistant  (NalR)
mutant of HK22 was isolated and alkB22 was P1-transducted to AB1157. In
this  way,  the  HK82  (alkB22  nalA)  and  HK80  (alkB+ nalA)  strains  were
constructed to determine the effect of alkB22 mutation on bacterial growth,
sensitivity to alkylating agents, and the type of MMS-induced mutations (Fig.
1A).
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BS87 (AB1157  alkB117)  strain has been obtained with the use of another
construct by Kataoka and Sekiguchi (1985) alkB mutant, HK117. The genetic
region encompassing gene  alkB,  on pHK12 plasmid (CmR)  was interrupted
with  transposon  Tn3,  derived  from  temperature-sensitive  pSC301::Tn3
(AmpR),  in  the  background of  HK82  strain,  thus  allowing  the  selection  of
pHK12  alkB::Tn3 mutants sensitive to MMS. One of the plasmids with Tn3
inserted  into  its alkB  gene,   pHK12-51,  was  recombined  with  the  MM386
genome (polAts) producing the HK117 (alkB‾) strain [6]. Growing P1 phage on
HK117 with subsequent transduction to AB1157, dr. Sedgwick obtained  E.
coli AB1157  alkB‾ marked as BS87 that harbors the  alkB117  with Tn3  an
insertional mutation [7] (Fig. 1B).
In our research published in 2006 [8], we have found at least 10-fold higher
level of MMS-induced argE3  Arg+ reversion in HK82 strain in comparison to
BS87 and the other alkB‾ mutant, MV1601 [9]. Here we showed that the  high
level of induced mutations in HK82 is due to a stronger induction of the SOS
response. Using comparative analysis of the genome sequence we failed to
indicate a single mutation responsible for  this  phenomenon, nevertheless,
several  divergences  that  we  discovered  in  HK82  genome  sequence  may
underline pecularly high activity of a mutagenic DNA repair network in this
strain. At the same time, HK82 has been the most and preferably used strain
in the AlkB studies, eg. [10-14]. By presenting results of our study, we wish to
inform  other  research  groups  working  on  AlkB  dioxygenase   about  the
differences between HK82 and BS87 to conclude that the use of HK82 as a
reference alkB‾ strain may cause false interpretation of experimental data. 
2. Materials and methods
2.1. Bacterial strains, plasmids, and media
All bacterial strains and plasmids used in this study are presented in Table 1.
The basis of this study are derivatives of  E. coli K-12 AB1157, HK82 (nalA
alkB22) constructed by Kataoka, Yamamoto and Sekiguchi (1983), and BS87
4
(alkB117)  constructed  by  Sedgwick  (1992).  Strains  representing  various
combinations  of  alkBwt,  alkB22,  alkB117,  and nalA mutations  in  the
backgrounds  of  AB1157,  HK82,  or  BS87,  as  well  as  HK82  sbcCwt were
prepared by P1 transduction [15]. The strains were selected on LB medium
containing antibiotics indicated in Table 1. MMS-sensitivity of the strains was
preliminarily checked by disc diffusion test with 2  l  of  MMS applied onto
each disc, and the alkB22 and alkB117 alleles distinguished by PCR reaction
(data not shown).
In  complementation experiments,  pMW1 [16],  pMW2, and pMW3 plasmids
were  used.  Plasmid  pMW2  was  constructed  by  cloning  the  PCR  product
encoding  the  ada-alkB operon,  produced  with  ada-pMW2-up   5’-
AGGGCTGGCGGTTTATATGATCAC-3’  and  alkB-pMW1-dn  5’-
CGCCAGACAAGTACAAGAAGTTCC-3’  primers,  into  pGB2  vector  plasmid  cut
with SmaI (NEB). The pMW3 was constructed by mutagenesis of the pMW2.
Frameshift mutation and TAA stop codon were formed by MluI (NEB) digestion
of  pMW2,  creation  of  blunt  ends  by  PolI  Klenow  fragment  (NEB)  and
relegation. Subsequently, only 98 amino acids of Ada protein could be formed
from pMW3.
The  liquid  media  were  LB  [15]  and  E  medium consisted  of  C  salts  [17],
glucose (0.5%), casamino acids (0.2%), and thiamine (10 µg/ml). The solid
media containing 1.5% Difco agar were LB and E-arg composed of C salts
supplemented with thiamine, glucose and a mixture of amino acids (proline,
leucine,  threonine  and  histidine),  each  at  25  µg/ml.  LCA  medium  was
composed of trypton (1%), yeast extract (0.5%), NaCl (1%), MgSO4 × 7H2O
(0.25%),  CaCl2 (2.5  mM),  and  Difco  agar  (0.6%)  [15].  If  necessary,
carbenicillin  (100 µg/ml),  kanamycin  (50 µg/ml),  nalidixic  acid (40 µg/ml),
spectinomycin  (50  µg/ml)   or  tetracycline  (20  µg/ml)  were  added  to  the
media. All bacterial variants were grown at 37°C.
Since  both  BS87  strain  and  pSK1002  plasmid  bear  the  resistance  to
carbenicillin,  BS87/pSK1002  transformants  were  selected  on  E-medium (C
salts supplemented with thiamine (10 µg/ml), glucose (0.5%), and casamino
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acids  (0.4%))  containing  X-gal  (5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside)  (40  µg/ml)  and  MMS  (2.5  mM).  Blue  colonies  were
selected and checked for the presence of pSK1002 plasmid DNA.
2.3. Mutagenesis assays
To test MMS-induced mutagenesis, bacteria were grown to OD600 0.6–0.7 in E
medium, treated with 20 mM MMS for 15 min, diluted 1:10 in E medium,
grown overnight to express mutations, and spread on the LB plates for viable
cells (one day of incubation at 37oC), LB was supplemented with rifampicin
(100  g/ml) for RifR mutants, and on E-arg for Arg+ revertants (two days of
incubation  at  37oC).  Following  the  counts,  frequency  of  mutations  was
expressed as the number of mutants per 108 cells. The spontaneous level of
mutations was assigned as a control.
Mutagenesis experiments were repeated 4-8 times, and standard deviation ±
SD was calculated. 
2.4. Expression of β-galactosidase
AB1157, AB1157  alkB22  zfa-3145::Tn10kan, HK82  zfa-3145::Tn10kan alkB+,
HK82,  and  BS87  were  transformed  with  pSK1002  plasmid  harboring  a
umuC::lacZ fusion [18, 19]. An overnight culture in LB was diluted 10-fold,
treated with 20 mM MMS for 15 min, centrifuged, resuspended in the same
volume  of  fresh  medium,  and  incubated  with  shaking  for  1-4  h.  At
appropriate time points, aliquots were taken and β-galactosidase activity was
estimated according to [15].
2.5.Next generation genome sequencing 
Genomic  DNA (gDNA) was  purified from the BS87 and HK82 cells  by the
CTAB/lysozyme method [20] and DNA concentrations were determined with
the Qubit dsDNA BR Assay Kit (Invitrogen).  The gDNAs were used to create
the genomic libraries using the KAPA Library Preparation kit, Illumina series
(Kapa Biosystems). The concentration of DNA libraries was checked by qPCR
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using  the  Illumina  Library  Quantification  kit  LightCycler  480-qPCR  mix.
Sequencing  was  performed  with  v3,  2×300  bp  chemistry  on  the  MiSeq
platform (Illumina).
The raw data was trimmed and cleaned for adaptors and assembled using
Newbler v.3.0 (454 Life Sciences Corporation). Superscaffolds were annotated
on the RAST server (Rapid Annotation Subsystem Technology) v.2.0. For SNP-
calling,  Geneious  R6  v.  6.1.8  (Biomatters  Ltd)  was  used  with  BS87  as  a
reference sequence.
3. Results and discussion
3.1. Characterization  of  MMS-induced  mutagenesis  in  BS87  and  HK82
strains
AlkB protein plays a protective role against the mutagenic action of MMS,
thus mutations of its key amino acid residues sensitize bacterial cells to this
alkylating  agent.  Our  published  results  [8]  have  shown  strongly  elevated
sensitivity of HK82 as well as BS87 mutants to MMS in comparison to the
AB1157 counterpart. In spite of similar survival, these  alkB‾ mutants have
presented different mutational responses to MMS treatment. In HK82 strain,
the level of MMS-induced Arg+ revertants has been at least 10-fold higher
than that in BS87 (Fig. 2). Additionally, the specificity of MMS-induced Arg+
revertants differs fundamentally between BS87 and HK82 strains. In BS87,
Arg+ revertants arise mainly by supB and supEoc suppressor formation due to
the  GC→AT  transitions  in  contrast  to  HK82  strain  where  the  AT→TA
transversions arising by supL suppressor formation prevail [8].
In order to explain whether the differences between BS87 and HK82 result
from the type of alkB mutation, i.e. the point mutation at alkB22 locus vs. the
transposon insertion in the  alkB  gene,  alkB117 (alkB::Tn3), a series of the
strains with different alkB alleles and selected backgrounds were constructed
(Table 1). Briefly, the alkB22 was replaced for the alkB117 in HK82 and vice
versa in BS87. Additionally, the total alkB deletion allele, alkB::kan, was also
tested  in  the  HK82  genetic  background.  Moreover,  the  wild  type  alkB+
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phenotype was recovered in HK82 and the  alkB22  allele was introduced to
the  new  AB1157  background.  In  all  the  constructs,  the  MMS-induced
mutagenesis was tested. As it was shown in Fig. 2, the increased level of Arg+
revertants was always observed in the HK82 background, irrespective of the
type of mutated alkB allele. On the other hand, the alkB22 showed the same
effect  as  alkB117 and  alkB::kan when  present  in  AB1157  or  BS87
backgrounds.
Interestingly, the differences in the level of MMS-induced mutations between
HK82  and  BS87  concerned  only  the  argE3Arg+ reversions  whereas  the
RifSRifR mutants remained at the same level (Fig. 2).  As we proved before,
the argE3Arg+ reversion system enables detection of mutations arising from
lesions in ssDNA and is especially useful for studies on induced mutagenesis
in E. coli alkB‾ strains [16, 21, 22]. Most of the MMS-induced Arg+ revertants
in  the  alkB‾ mutants  arise  by  tRNA  suppressor  formation  [8].  The  tRNA-
encoding genes are heavily transcribed and exist mostly as ssDNA in cells.
On the  contrary,  rifampicin  resistance results  from mutations  in  the  rpoB
gene encoding  subunit of RNA polymerase, assumed to be in the form of
dsDNA for most of the time. Moreover, the increased level of mutagenesis in
HK82 in comparison to BS87 is possibly specific to the mutagenic agent (e.g.
MMS) inducing both, the SOS and Ada regulons since no differences in the
level of UV-induced mutations in both tested strains were observed (data not
shown).
3.2. Induction of SOS response in alkB mutants
The difference between HK82 and BS87 was also noticed in the level of β-
galactosidase  induction  measured  in  these  strains  harboring  pSK1002
plasmid bearing umuC::lacZ fusion, where the lacZ gene remains under the
control of umuC promoter. The fusion gene has been expressed in response
to SOS induction. We have found 2-fold stronger β-galactosidase induction in
MMS-treated HK82 in comparison to BS87 strain (Fig. 3). It is noteworthy that
induction of β-galactosidase in the AB1157  alkB22  strain is comparable to
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that  of  BS87,  and  lower  than  that  of  HK82.  Moreover,  β-galactosidase
induction  in  HK82  alkB+ is  stronger  than  in  AB1157.  Since  these  results
indicate the induction of SOS response, we conclude that the HK82 strain
shows elevated activation of essential DNA repair systems that remain under
the  control  of  SOS  regulon.  Taken  together,  the  increased  MMS-induced
mutagenesis  measured  by  the  argE3Arg+ reversion  system,  different
spectrum of mutations, and induced SOS response point to the conclusion
that  there  should  be  additional,  AlkB-independent  source  of  mutations  in
HK82 strain. 
3.3. The  impact  of  Ada  response  on  the  frequency  of  MMS-induced
mutations in alkB mutants
Since the main repair system counteracting alkylating agents in E. coli is the
Ada regulon, we performed a series of complementation assays in HK82 and
BS87  expressing  episomal  copies  of  Ada  regulon  components.  These
components include bifunctional Ada protein, a transcription factor activating
the Ada regulon and methyltransferase acting mainly on O6meG and O4meT,
and AlkA glycosylase repairing broad range of substrates including replication
blocking 3meA, and 7meA, 3meG, εA, and even excising normal bases from
DNA [23, 24]. Interestingly, overproduction of AlkB protein (Fig. 4) led to the
reduction of Arg+ revertants to 16%  in the BS87 strain, but only to about
48.4% in HK82. Further, simultaneous overexpression of three Ada proteins:
Ada, AlkA, and AlkB decreased the level of Arg+ revertants in MMS-treated
BS87 and HK82 up to 6.4 and 3%, respectively, whereas in the presence of
pMW3 plasmid mutated in ada gene respective values reached almost 10 and
34% (Fig. 4). These results suggest that AlkB protein alone is not sufficient to
repair  MMS-induced  lesions  in  HK82  strain,  but  all  three  Ada  response
proteins (Ada, AlkA, AlkB) contribute to the repair of a spectrum of lesions in
DNA produced by alkylating agent.
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3.4. Comparative analysis of genome sequence of HK82 and BS87 strains
in the light of their different responses to MMS action
To identify the factor(s) responsible for the malfunctioning of HK82 strain, we
performed  next  generation  genome  sequencing  of  HK82  and  BS87.  NGS
analysis identified several genes with non-synonymous mutations present in
HK82, listed in Table 2. Among others, they include  nalA,  sbcC,  and  nuoC
genes.
The  nalA codes for DNA gyrase subunit A. As it was mentioned earlier, the
spontaneous nalA mutant conferring the resistance against nalidixic acid and
other quinolone-based antibiotics assisted the transduction of alkB22 [5]. It is
widely accepted that the NalA region encompassing 67 – 106 amino acids
serves  as  the  drug  target  and  was  dubbed  the  quinolone  resistance-
determining region [25, 26]. As we have established, HK82 strain carries the
mutated nalA producing the NalA D87Y (Table 2). Although this mutation lies
in the 67 – 106 region, Barnard and Maxwell [27] found that the GyrA D87A
mutant was 2.5-fold less active in DNA supercoiling and 1.5-fold less active in
DNA cleavage [27]. Taken together, we tested the mutagenesis levels in the
E. coli cells with  nalA alone and with combination with  alkB22 and  alkB117
alleles in different backgrounds. As it is shown in Fig. 2, the presence of nalA
does not show any influence on the level of RifR mutants/Arg+ revertants in
AB1157 and its alkB‾ mutants, BS87 and HK82.
The  second  selected  candidate  was  the  sbcC gene  bearing  the  mutation
producing protein with a H333Y substitution (Table 2). The SbcC protein is a
subunit of SbcCD exonuclease complex dealing with hairpin and palindromic
sequences in DNA. Recently, the involvement of SbcCD exonuclease in DNA
repair,  especially  in  the  repair  of  double  strand  breaks,  was  established.
Additionally, the  sbcC and  sbcD together act as a suppressor of  recB/recC
mutations [28-32]. Bacillus subtilis cells devoid of sbcC gene are much more
sensitive  to  mitomycin  C  and  -irradiation  than  wt  strain  [33].  Our
bioinformatic  analysis  did  not  confirm the H333 position  as  laying  in  the
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region important for the protein activity, and this region does not seem to be
highly conserved (data not shown). Additionally,  the HK  sbcCwt nalA strain
shows similar level of mutations as HK82 counterpart (Fig. 2).
Recently, it was revealed that other genes not directly linked to DNA repair,
function in the cell response to DNA double strand breaks [34]. The  nuoC,
producing one of the subunits of NADH-ubiquinone oxidoreductase takes part
in  this  pathway.  These genes are under  the  control  of  RpoE transcription
factor responsible for the activation of stress responses to e.g. heat shock
and oxidative stress [35]. To test whether HK82 is deficient in the response
controlled by RpoE, the sensitivity of this strain to 0.5% SDS and 0.55 – 1.1
mM EDTA was checked by a serial dilution drop test (data not shown). The
tested strain did not show an impaired membrane-protein stress response,
thus proving to exert properly functioning RpoE pathway being in agreement
with  observed similar  levels  of  RifR mutants  in  different  variants  of alkB‾
strains treated with MMS.
It  can be speculated that  while  particular  mutations  in  nalA,  sbcC and/or
nuoC alone do not show any effect on the DNA metabolism,  when present in
the  alkB‾ background may be a source of ssDNA fragments leading to the
induction of two protective responses, SOS and Ada, after MMS treatment.
This  induction  is  at  a  much  higher  level  in  the  HK82  strain  expressing
mutated AlkB than in cells exclusively deprived of the functional enzyme.
4. Conclusions
As a tools for exploring the impact of AlkB dioxygenases on the repair of
alkylation lesions in nucleic acids, we have used two  E. coli alkB mutants,
HK82 and BS87. However, we have found several undesirable features of the
former strain and shared this knowledge at several international conferences.
Unfortunately, we were not able to present precise data on the subject. Only
now we could  prove that  HK82 is  not  an  exact  derivative  of  the original
AB1157 strain because it bears several additional mutations in its genome
that may influence MMS-induced SOS and Ada responses giving almost out of
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control high levels of MMS-induced mutations. Thus, we recommend using
BS87 as a reference alkB‾ strain for AlkB studies. 
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Table 1. E. coli strains and plasmids used in this study.
Strain/Relevan
t genotype
P1 donor P1
acceptor
Comments/Relevant
fenotype
Reference
AB1157 - - thr-1,  ara-14,
leuB6,  Δ(gpt-
proA)62, lacY1, tsx-
33,  supE44,  galK2,
rac–,  hisG4(Oc),
rfbD1,  mgl-51,
rpsL31,  kdgK51,
xyl-5,  mtl-1,  argE3
[36]
14
(Oc), thi-1, qsr
CAG12080 - - λ-, mhpC281::Tn10,
rph-1; TetR
[37]
CAG12148 - - λ-, tsx-247::Tn10,
rph-1; TetR
[37]
CAG12183 - - λ-,  gyrA-0(NalR),  zfa-
3145::Tn10kan,  rph-
1;  donor  of  Tn10
insertion; KanR
[37]
HK82 - - As  AB1157  but
alkB22 nalA; NalR
[5]
BS87 - - As  AB1157  but
alkB117; AmpR
[7]
DM12 - - As  AB1157  but
alkB::kan; KanR
[4]
HK82  zfa-
3145::Tn10ka
n
CAG12183 HK82 As  HK82  but  with
Tn10kan  inserted  in
the vicinity of alkB22;
KanR
this study
AB1157 nalA
HK82 AB1157 alkB+ NalR
HK82  zfa-
3145::Tn10
kan
AB1157 alkB+ NalR KanR
AB1157
alkB22 nalA
HK82 zfa-
3145::Tn10
kan
AB1157 alkB22 NalR KanR
HK82  alkB+
nalA 
CAG12183 HK82 alkB+ NalR KanR
HK82 alkB117 BS87 HK82 alkB117 AmpR
HK82  alkB117
nalA
BS87 HK82 alkB117 AmpR NalR
HK82
alkB::kan
DM12 HK82 alkB::kan KanR
HK82
alkB::kan nalA
HK82 alkB::kan KanR NalR
BS87 nalA
HK82 BS87 alkB117 AmpR NalR
HK82 zfa-
3145::Tn10
kan
BS87 alkB117  AmpR NalR
KanR
BS87 alkB22 
nalA
HK82 BS87 alkB22 NalR
HK82 zfa-
3145::Tn10
kan
BS87
alkB22 NalR KanR
HK82 sbcCwt CAG12080 HK82 alkB22 Nal
R TetR
CAG12148 HK82 alkB22 NalR TetR
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Plasmid Genotype
pSK1002 umuC::lacZ fusion [18]
pGB2 SpcR,  low-copy  pSC101  derivative  with  mp8
polylinker
[38]
pMW1 alkB inserted into pGB2 [16]
pMW2 ada, alkB, and alkA inserted into pGB2 this studypMW3 As pMW2 but ada–
Table 2. Non-synonymous mutations identified in HK82 genome.
BS8
7 
bas
e
HK8
2 
base
Impact SNP %
Gene ID
(Locus 
name)
Feature Name DNAChange
Protein
Chang
e
G A
Non 
synonymo
us
100.0 946759(b2286)
NADH-ubiquinone 
oxidoreductase 
NuoC
c.637G>A E213K
G T
Non 
synonymo
us
100.0 946614(b2231)
DNA gyrase 
subunit A
GyrA
c.259G>T D87Y
G A
Non 
synonymo
us
100.0 946708(b2212)
Alkylated DNA 
repair protein 
AlkB
c.397G>A D133N
A G
Non 
synonymo
us
100.0 945011(b0054)
Outer membrane 
protein
Imp
c.1808A>
G M603T
A C
Non 
synonymo
us
95.7 948243(b3733)
ATP synthase 
gamma chain
AtpG
c.194A>C H65P
A T
Non 
synonymo
us
96.2 949002(b1211)
Peptide chain 
release factor 1
PrfA
c.401A>T M134K
C T
Non 
synonymo
us
100.0 949076(b0397) Exonuclease SbcC c.997C>T H333Y
T - Frameshift 90.0 948449(b0022) InsA-1 c.115T>- Q38fs
T C 52.2 5S rRNA
Figure legend:
Fig. 1. Diagram representing the construction procedures for  E. coli HK82
and BS87 strains. The basis for HK82 construction was chemical mutagenesis
that allowed the isolation of the spontaneous alkB22 mutant, the allele was
16
transferred to AB1157 strain by P1 trasnduction with  nalA  as a marker (A).
Contrariwise,  the  BS87  was  constructed  owing  to  transposon  insertional
mutangenesis of  alkB allele present on plasmid, subsequently recombined
with polAts strain, and transduced to AB1157 (B).
Fig. 2. Frequency of MMS-induced mutagenesis measured by Arg+ reversion
and RifR mutation in E. coli AB1157, HK82, BS87, and their derivatives. 
Fig. 3. Complementations studies of HK82 and BS87 strains with selected
Ada response components bearing on plasmids: pMW1 – alkB, pMW2 – alkB,
alkA, and ada, and pMW3 – alkB, alkA, and mutated ada.
Fig. 4. The SOS induction in MMS-treated AB1157, HK82, and BS87 strains
and their derivatives based on -galactosidase expression from a umuC::lacZ
fusion.
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Dear Editor,
Enclosed, please find the manuscript entitled „Evaluation of the E. coli HK82
and BS87 strains as tools for AlkB studies”, authors: Mielecki  D, Sikora A,
Wrzesiński  M,  Nieminuszczy  J,  Detman  A,  Żuchniewicz  K,  Gromadka  R,
Grzesiuk E.
In  the  light  of  intensive  studies  on  AlkB  dioxygenases,  it  is  of  the  great
importance to have precisely defined mutant in alkB gene. Among two E. coli
alkB‾ strains,  Kataoka’s HK82 and Sedgwick’s BS87, the former is the most
frequently used even in papers published this year. Our team, led by prof.
Celina Janion, have observed unlike features of HK82 e.g. extremely high and
variable MMS-induced mutagenesis, but only now we get tools to prove that
HK82 contains several additional mutations in its genome, thus is not exact
AB1157 derivative and shows other features which disqualify it as a reference
strain for AlkB studies. Consequently, BS87 is a proper AB1157 derivative and
should be used instead.
I hope you find this work important for scientific community working on DNA
repair, specifically on AlkB dioxygenases, and suitable for publication in DNA
Repair.
Sincerely,
Prof. Elżbieta Grzesiuk.
